is semaglutide safe for liver Can Cause Damage? Safety Evidence Explained Semaglutide GLP-1 for Medical Weight

10.1016/j.cmet.2014.09.018 46 ForetzM.GuigasB.ViolletB

Zepbound (tirzepatide) was studied in adults up to age 75 in major clinical trials, and safety data show that advancing age is not a contraindication to GLP-1 therapy

The FDA granted plozasiran Breakthrough Therapy, Fast Track and Orphan Drug designations

As fat loss slows and body weight stabilizes, maintenance protein intake is typically slightly lower

Changes in Gum Health Dry mouth, changes in hydration, and shifts in eating habits may contribute to gum irritation or sensitivity in some patients

Current FDA labeling for semaglutide products highlights this pathway: stomach and bowel side effects can lead to volume depletion, and acute kidney injury has occurred, including in postmarketing reports